End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.87 CAD | +0.75% | +1.65% | +40.06% |
Sales 2024 * | 42.98B 58.56B | Sales 2025 * | 52.62B 71.7B | Capitalization | 739B 1,006B |
---|---|---|---|---|---|
Net income 2024 * | 11.93B 16.26B | Net income 2025 * | 16.55B 22.55B | EV / Sales 2024 * | 17.6 x |
Net Debt 2024 * | 18.07B 24.62B | Net Debt 2025 * | 15B 20.43B | EV / Sales 2025 * | 14.3 x |
P/E ratio 2024 * |
61.4
x | P/E ratio 2025 * |
44.2
x | Employees | 43,000 |
Yield 2024 * |
0.63% | Yield 2025 * |
0.73% | Free-Float | 99.8% |
Latest transcript on Eli Lilly and Company
1 day | +0.75% | ||
1 week | +1.65% | ||
1 month | +5.47% | ||
3 months | +4.57% | ||
6 months | +39.81% | ||
Current year | +40.06% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 95-12-31 |
Anat Ashkenazi
DFI | Director of Finance/CFO | 51 | 00-12-31 |
Ruth Gimeno
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 21-01-24 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 09-03-31 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 30.87 | +0.75% | 22,302 |
24-05-30 | 30.64 | +0.49% | 19,580 |
24-05-29 | 30.49 | +0.63% | 18,814 |
24-05-28 | 30.3 | -2.26% | 34,745 |
24-05-27 | 31 | +2.07% | 3,375 |
End-of-day quote NEO Exchange, May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- LLY Stock
- LLY Stock